Bio-Techne – Medical Alley Association

Bio-Techne

In the Know: Healthcare News for Nov. 4, 2019

Bio-Techne will open $40M+ facility in St. Paul IBM, Mayo Clinic, Geisinger among 25 finalists for $1.6M CMS artificial intelligence challenge Medtronic wins FDA breakthrough nod for fully implantable LVAD Minnesota Startups Raised $70.8M in Q3 Boston Sci Gives Update on the Measured Launch of Lotus Edge Meet The Most Disruptive MBA Startups Of 2019 […]

In the Know: Healthcare News for October 14, 2019

Phase 2 Results: Microbiota-Based RBX2660 Safe, Efficacious for Preventing C diff Recurrence Medtronic Bids for FDA Approval of OAB/FI Neuromodulation Device – MassDevice Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta This Is the Strongest Pipeline in Medtronic’s History Funding Roundup: 4C Medical Spineology Seek Millions West Monroe […]

Medicare Issues Final Local Coverage Decision for Bio-Techne’s ExoDx Prostte (IntelliScore) Test

MINNEAPOLIS, Oct. 10, 2019/PRNewswire/ – Bio-Techne Corporation (NASDAQ:TECH) today announced that the Medicare Administrative Contractor (MAC) National Government Services, Inc. issued a final Local Coverage Decision (LCD) covering the ExoDx Prostate(IntelliScore) – EPI – test for men who are being considered for an initial prostate biopsy. The decision is effective for tests administered on or […]

Bio-Techne Leverages the RNAscope Technology to Advance a Multiomic Approach to Antibody Validation

MINNEAPOLIS, Oct. 7, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of immunohistochemistry (IHC) antibodies using the Advanced Cell Diagnostics-branded RNAscope in situ hybridization (ISH) platform to leverage its transcriptomics approach […]

In the Know: Healthcare News for Sept. 23, 2019

MAA Congratulates Jodi Hubler on Her Appointment to Launch Minnesota Advisory Board CEOs of Minnesota’s biggest health players take aim AI myths Senate lawmakers direct CMS to boost non-opioid device reimbursement UEL Joins BARDA Accelerator Network University of Minnesota discovery is now a first-in-human clinical trial for leukemia 3M and M*Modal Combine Advanced Technologies to […]

Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility

MINNEAPOLIS, Sept. 16, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing facility in Flowery Branch, Georgia. ISO 9001:2015 is an international Business Quality Management System standard that is recognized globally as an indicator of quality excellence. This certification […]

In the Know: Healthcare News for August 27, 2019

Blue Cross and Blue Shield of Minnesota to drop insulin co-pay to $0 CVRx Receives FDA Approval for World’s First Heart Failure Neuromodulation Device Q&A: ‘The key is going to be providing information that’s actually helpful’ U.S. health care system must adopt nimbler, more transparent model Starkey Hearing Technologies Named Stevie Awards Winner New cancer […]

Bio-Techne Introduces Maurice Empower® Control Kit for the Maurice System

MINNEAPOLIS, August 20, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower® Control Kit for the ProteinSimpleTM- branded Maurice platform. This new kit enables users to collect, manage and report Maurice results with the industry leading Empower® 3 Software from WatersTM Corporation. Since its introduction in 2016, the Maurice platform […]

In the Know: Healthcare News for August 19, 2019

Fairview acquires Wisconsin-based Vibrant Health AtriCure offers $300m for SentreHeart Bio-Techne: $50m reagent plant support cell & genes Mayo Clinic invests in breast cancer imaging AI We’re Starting to Harness the Microbiome to Treat Disease Despite a Cold M&A Market in Minnesota, Deal Activity in Healthcare Remains Hot UK regulators OK Boston Scientific’s $4B BTG […]

Bio-Techne and Cygnus Technologies Announce Partnership for 3G CHO-HCP Assay

MINNEAPOLIS and SOUTHPORT, August 13, 2019/PRNewswire/ — Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimpleTM-branded EllaTM immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the co-developed third generation CHO-HCP assay […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER